For the past 16 years, leading drug and medical device lawyers have gathered in New York to network with their peers, and craft strategies to surmount new litigation challenges. Now in its 17th year, ACI’S DRUG AND MEDICAL DEVICE LITIGATION is widely regarded as the year’s must attend industry event.
Network with the “who’s who” in the products liability space
This year’s speaking faculty is comprised of more than 30 in-house counsel, the law firm litigators who have handled the biggest cases, prominent government enforcers, and renowned members of the state and federal bench, providing advice for defeating claims and litigating more efficiently. ACI is also pleased to announce that Timothy Pratt, Executive Vice President, Chief Administrative Officer, General Counsel and Secretary at Boston Scientific Corporation, will be offering keynote remarks.
Learn how industry peers are addressing: products liability suits post-Mensing, tightening litigation budgets, increasing globalization and shareholder derivative suits
Drug and device manufacturers may finally have clarity when it comes to safety warnings, labeling, and the responsibility of the generic manufacturers. The attorneys on the front lines of industry changing litigation will share their insights and offer strategies for
- Dealing with creative plaintiffs’ counsel
- Responding as co-defendants when both brand and generic manufacturers are cited in a complaint
- Streamlining the litigation process and disposing of cases expeditiously in a tough economy
- Defending against allegations of breach of fiduciary duty
- Coordinating a global litigation strategy
For more information, please visit our website: http://www.drugandmed.com
Medical News Today readers are entitled to a discount when referencing the code: MNT 200
Drug and Med conference